Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis - Quiz - MDSpire

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

  • By

  • Derek Tai

  • Kyung-il Kim

  • Pranati Shah

  • Daniel Park

  • Lucas Kim

  • Jianan Li

  • Claire Jung

  • Sofia Guzman

  • Gagandeep Brar

  • Shengyang Wu

  • Dani Castillo

  • June 29, 2026

  • 0 min

Share

Original Source(s)

Impact of metastatic pattern and histologic subtype on PD-(L)1 inhibitor efficacy in HER2-negative advanced gastric and gastroesophageal cancer: a meta-analysis

  • by Derek Tai, Kyung-il Kim, Pranati Shah, Daniel Park, Lucas Kim, Jianan Li, Claire Jung, Sofia Guzman, Gagandeep Brar, Shengyang Wu, Dani Castillo

  • June 29, 2026

Related Content

Coexistence of lymphoplasmacytic lymphoma and multiple myeloma: a case report and review of literature

ESMO Breast Cancer 2026 Highlights: Saci-IO HR+

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss results from the Saci-IO HR+ trial, which were presented at the 2026 ESMO Breast Cancer Congress.

  • June 26, 2026

  • 1 min
A label-free nanoplasmonic biosensor for intraoperative discrimination of tumor margins in brain metastases surgery